This state-of-art technology will help pulmonologists to diagnose lung cancer in the very early stages helping the patient get an early surgical resection
Company announced that it is accelerating its investment in its Leaps by Bayer impact investment unit with more than 1.3 billion euros funding until end of 2024
WHO’s post EUA inspection found deficiencies in Good Manufacturing Practice at the facility
The launch of medical cannabis products resulted from an agreement between the two companies signed in 2021
Through this consortium, Lonza will collaborate with other industry leaders to advance the research and development of inhalation technologies
The new structure further transitions the Health Care business line into a system solutions partner for the pharmaceutical and biotech industries
One of the most advanced cancer care centres in the state of Odisha, it is equipped with the latest technology and a highly experienced multi-disciplinary team of oncologists
Bayer will be setting up 27 telemedicine centres in 12 districts across 8 states with implementing partners Telerad RxDx and Piramal Swasthya
It is one of the 15 medical device manufacturers approved under the government’s PLI scheme
Celerity Pharmaceuticals uses Biocon Biologics’ insulin drug substance to develop the product
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
